Join the club for FREE to access the whole archive and other member benefits.
Shreds multiple critical stretches of bacteria's DNA at the same time
Key points from article :
Locus Biosciences to develop a radical new way to kill bacteria.
Uses Crispr Cas3 to shred critical stretches of bacteria's DNA.
Should prevent evolving resistance by targeting multiple genes at the same time.
Human clinical trials planned this year.
Initially aimed at lung infections.
Just announced a $818 million deal with Janssen Pharmaceuticals.
The study was published in The British Medical Journal.
Click on resource name for more details.
Assistant Professor of Pediatrics and Communicable Diseases at University of Michigan Medical School
Biotechnology company developing CRISPR-engineered precision antibacterial products.
